Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release


Posted on: 21 Dec 17

New York, NY, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announced the payment of a dividend for 2017.  The Board of Directors has unanimously approved an annual dividend payment of $0.03 per share. This dividend will be paid on Friday, December 29, 2017 to Daxor shareholders of record on Thursday, December 21, 2017.

Daxor Corporation manufactures and markets the BVA-100 Blood Volume Analyzer, which is used in conjunction with Volumex, Daxor’s single-use diagnostic kit.  For more information regarding blood volume analysis and the Daxor BVA-100, visit Daxor’s website at

CONTACT: Daxor contact information: Michael Feldschuh, President and CEO. 212-330-8505 John Wilkens, Chief Financial Officer. 212-330-8504 GlobeNewswire

Last updated on: 21/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.